Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18501079 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
Condition: Kidney Cancer
Intervention: Biological: PEG-interferon alfa-2b

Study has passed its completion date and status has not been verified in more than two years.